CytomX Therapeutics, Inc. Increase (Decrease) in Accounts Payable
CytomX Therapeutics, Inc. (CTMX) reported Increase (Decrease) in Accounts Payable of $638.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- CytomX Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $571.00K.
- CytomX Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $67.00K.
- CytomX Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $655.00K.
- CytomX Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $419.00K, a 48.34% decline year-over-year.
- CytomX Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2025 was $221.00K.
- CytomX Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2024 was -$297.00K.
- CytomX Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2023 was -$1.43M, a 2197.06% decline from fiscal 2022.
- CytomX Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2022 was $68.00K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $571.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $638.00K 10-Q · filed 2026-08-06 | $1.29M derived: sum of 3 quarters · filed 2026-08-06 | $1.71M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $67.00K 10-Q · filed 2026-05-07 | $722.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.14M derived: sum of 3 quarters · filed 2026-05-07 | $1.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $655.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $1.07M derived: sum of 2 quarters · filed 2026-03-16 | $1.02M derived: sum of 3 quarters · filed 2026-08-06 | $221.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | $419.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $370.00K derived: sum of 2 quarters · filed 2026-08-06 | -$434.00K 10-Q · filed 2025-11-06 | -$695.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$853.00K 10-Q · filed 2026-08-06 | -$1.11M derived: sum of 3 quarters · filed 2026-08-06 | -$303.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$804.00K 10-Q · filed 2026-05-07 | -$1.06M derived: sum of 2 quarters · filed 2026-05-07 | -$254.00K derived: sum of 3 quarters · filed 2026-05-07 | -$1.68M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$261.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $550.00K derived: sum of 2 quarters · filed 2026-03-16 | -$878.00K derived: sum of 3 quarters · filed 2026-03-16 | -$297.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $811.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$617.00K derived: sum of 2 quarters · filed 2025-11-06 | -$36.00K 10-Q · filed 2025-11-06 | -$364.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$847.00K 10-Q · filed 2025-08-07 | -$1.18M derived: sum of 3 quarters · filed 2025-08-07 | -$499.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $581.00K 10-Q · filed 2025-05-12 | $253.00K derived: sum of 2 quarters · filed 2025-05-12 | $929.00K derived: sum of 3 quarters · filed 2025-05-12 | -$227.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$328.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $348.00K derived: sum of 2 quarters · filed 2025-03-06 | -$808.00K derived: sum of 3 quarters · filed 2025-03-06 | -$1.43M 10-K · filed 2025-03-06 |
| 2023-09-30 | $676.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$480.00K derived: sum of 2 quarters · filed 2024-11-07 | -$1.10M 10-Q · filed 2024-11-07 | -$3.47M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.77M 10-Q · filed 2024-08-08 | -$4.15M derived: sum of 3 quarters · filed 2024-08-08 | -$862.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$618.00K 10-Q · filed 2024-05-08 | -$2.99M derived: sum of 2 quarters · filed 2024-05-08 | $294.00K derived: sum of 3 quarters · filed 2024-05-08 | $510.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $912.00K derived: sum of 2 quarters · filed 2024-03-11 | $1.13M derived: sum of 3 quarters · filed 2024-03-11 | $68.00K 10-K · filed 2024-03-11 |
| 2022-09-30 | $3.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $3.50M derived: sum of 2 quarters · filed 2023-11-07 | $2.44M 10-Q · filed 2023-11-07 | $3.66M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $216.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$844.00K 10-Q · filed 2023-08-08 | $375.00K derived: sum of 3 quarters · filed 2023-08-08 | $190.00K derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$1.06M 10-Q · filed 2023-05-09 | $159.00K derived: sum of 2 quarters · filed 2023-05-09 | -$26.00K derived: sum of 3 quarters · filed 2023-05-09 | -$907.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.22M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | $1.03M derived: sum of 2 quarters · filed 2023-03-27 | $153.00K derived: sum of 3 quarters · filed 2023-03-27 | -$139.00K 10-K/A · filed 2023-03-27 |
| 2021-09-30 | -$185.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$1.07M derived: sum of 2 quarters · filed 2022-11-08 | -$1.36M 10-Q · filed 2022-11-08 | -$1.95M derived: sum of 4 quarters · filed 2023-03-27 |
| 2021-06-30 | -$881.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$1.17M 10-Q · filed 2022-08-04 | -$1.76M derived: sum of 3 quarters · filed 2023-03-27 | -$2.61M derived: sum of 4 quarters · filed 2023-03-27 |
| 2021-03-31 | -$292.00K 10-Q · filed 2022-05-05 | -$879.00K derived: sum of 2 quarters · filed 2023-03-27 | -$1.73M derived: sum of 3 quarters · filed 2023-03-27 | -$1.20M derived: sum of 4 quarters · filed 2023-03-27 |
| 2020-12-31 | -$587.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | -$1.44M derived: sum of 2 quarters · filed 2023-03-27 | -$909.00K derived: sum of 3 quarters · filed 2023-03-27 | -$857.00K 10-K/A · filed 2023-03-27 |
| 2020-09-30 | -$849.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$322.00K derived: sum of 2 quarters · filed 2021-11-04 | -$270.00K 10-Q · filed 2021-11-04 | -$796.00K derived: sum of 4 quarters · filed 2023-03-27 |
| 2020-06-30 | $527.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $579.00K 10-Q · filed 2021-08-05 | $53.00K derived: sum of 3 quarters · filed 2023-03-27 | $202.00K derived: sum of 4 quarters · filed 2023-03-27 |
| 2020-03-31 | $52.00K 10-Q · filed 2021-05-06 | -$474.00K derived: sum of 2 quarters · filed 2023-03-27 | -$325.00K derived: sum of 3 quarters · filed 2023-03-27 | -$5.48M derived: sum of 4 quarters · filed 2023-03-27 |
| 2019-12-31 | -$526.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | -$377.00K derived: sum of 2 quarters · filed 2023-03-27 | -$5.54M derived: sum of 3 quarters · filed 2023-03-27 | -$374.00K 10-K/A · filed 2023-03-27 |
| 2019-09-30 | $149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$5.01M derived: sum of 2 quarters · filed 2020-11-05 | $152.00K 10-Q · filed 2020-11-05 | -$2.38M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | -$5.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $3.00K 10-Q · filed 2020-08-06 | -$2.53M derived: sum of 3 quarters · filed 2021-02-24 | $693.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $5.16M 10-Q · filed 2020-05-07 | $2.63M derived: sum of 2 quarters · filed 2021-02-24 | $5.85M derived: sum of 3 quarters · filed 2021-02-24 | $4.31M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | -$2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $690.00K derived: sum of 2 quarters · filed 2021-02-24 | -$854.00K derived: sum of 3 quarters · filed 2021-02-24 | $261.00K 10-K · filed 2021-02-24 |
| 2018-09-30 | $3.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $1.68M derived: sum of 2 quarters · filed 2019-11-07 | $2.79M 10-Q · filed 2019-11-07 | $3.85M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$429.00K 10-Q · filed 2019-08-07 | $625.00K derived: sum of 3 quarters · filed 2020-02-27 | -$2.95M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $1.11M 10-Q · filed 2019-05-09 | $2.17M derived: sum of 2 quarters · filed 2020-02-27 | -$1.41M derived: sum of 3 quarters · filed 2020-02-27 | $1.50M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$2.52M derived: sum of 2 quarters · filed 2020-02-27 | $384.00K derived: sum of 3 quarters · filed 2020-02-27 | -$2.44M 10-K · filed 2020-02-27 |
| 2017-09-30 | -$3.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$670.00K derived: sum of 2 quarters · filed 2018-11-06 | -$3.50M 10-Q · filed 2018-11-06 | $2.33M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $79.00K 10-Q · filed 2018-08-08 | $5.90M derived: sum of 3 quarters · filed 2019-02-27 | $5.05M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | -$2.83M 10-Q · filed 2018-05-09 | $3.00M derived: sum of 2 quarters · filed 2019-02-27 | $2.15M derived: sum of 3 quarters · filed 2019-02-27 | -$1.31M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $5.82M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $4.97M derived: sum of 2 quarters · filed 2019-02-27 | $1.52M derived: sum of 3 quarters · filed 2019-02-27 | $1.76M 10-K · filed 2019-02-27 |
| 2016-09-30 | -$853.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$4.30M derived: sum of 2 quarters · filed 2017-11-07 | -$4.06M 10-Q · filed 2017-11-07 | -$1.86M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | -$3.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$3.21M 10-Q · filed 2017-08-07 | -$1.01M derived: sum of 3 quarters · filed 2018-03-07 | $588.00K derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | $246.00K 10-Q · filed 2017-05-05 | $2.44M derived: sum of 2 quarters · filed 2018-03-07 | $4.04M derived: sum of 3 quarters · filed 2018-03-07 | $3.76M derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | $2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | $3.79M derived: sum of 2 quarters · filed 2018-03-07 | $3.51M derived: sum of 3 quarters · filed 2018-03-07 | $2.94M 10-K · filed 2018-03-07 |
| 2015-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $1.32M derived: sum of 2 quarters · filed 2016-11-03 | $749.00K 10-Q · filed 2016-11-03 | $965.00K derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-06-30 | -$283.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$850.00K 10-Q · filed 2016-08-03 | -$634.00K derived: sum of 3 quarters · filed 2017-03-02 | |
| 2015-03-31 | -$567.00K 10-Q · filed 2016-05-06 | -$351.00K derived: sum of 2 quarters · filed 2017-03-02 | ||
| 2014-12-31 | $216.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $660.00K 10-K · filed 2017-03-02 | ||
| 2014-09-30 | $444.00K 10-Q · filed 2015-11-23 | |||
| 2013-12-31 | $366.00K 10-K · filed 2016-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |